Overview

Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes

Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
0
Participant gender:
All
Summary
Recent clinical trials in non diabetics showed that vitamin D supplementation markedly reduced serum levels of C-reactive protein (CRP), interleukin-6, and tissue matrix metallo-proteinases. Our study objective is to evaluate if administration of vitamin D in African Americans with hypovitaminosis D and DM Type 2 decreases serum levels of inflammatory/thrombotic markers such as CRP: Highly Sensitive C Reactive Protein.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
John H. Stroger Hospital
Collaborator:
Rush University
Treatments:
Ergocalciferols
Vitamin D
Vitamins
Criteria
Inclusion Criteria:

- African Americans

- DM type 2

Exclusion Criteria:

- symptomatic vitamin D deficiency

- hypocalcemia

- hypercalcemia

- malabsorption

- liver disease

- patients with creatinine > 1.5. (CKD >/= 3)

- pregnancy